Aspergillosis in children with cancer: A 34-year experience

Clinical Infectious Diseases

Volumn 29, Issue 5, 1999, Pages 1210-1219

  Abbasi, Seema ^a   Shenep, Jerry L ^a   Hughes, Walter T ^a   Flynn, Patricia M ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLOSIS; CANCER PATIENT; CHILD; CHILDHOOD CANCER; CHILDHOOD DISEASE; FEMALE; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; INFECTION SENSITIVITY; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL;

ADOLESCENT; ASPERGILLOSIS; BONE DISEASES, INFECTIOUS; CHILD; CHILD, PRESCHOOL; DERMATOMYCOSES; FEMALE; HUMANS; INFANT; MALE; NEOPLASMS; PARANASAL SINUS DISEASES; RETROSPECTIVE STUDIES;

EID: 0033512462     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313445     Document Type: Article

References (43)

1. 1. Arlet G, Gluckman E, Gerber F, Perol Y, Hirsch A. Measurement of bacterial and fungal air counts in two bone marrow transplant units. J Hosp Infect 1989;13:63-9.
2. 2. Sarubbi F, Kopf H, Wilson B, McGinnis M, Rutala W. Increased recovery of Aspergillus flavus from respiratory specimens during hospital construction. Am Rev Respir Dis 1982;125:33-8.
3. 3. Wadowsky R, Benner S, Distribution of the genus Aspergillus in hospital room air conditioners. Infect Control 1987;8:516-8.
4. 4. Arnow P, Sadigh M, Costas C, Weil D, Chudy R. Endemic and epidemic aspergillosis associated with in-hospital replication of Aspergillus organisms. J Infect Dis 1991;164:998-1002.
5. 5. Andriole VT. Infections with Aspergillus species. Clin Infect Dis 1993; 17(Suppl 2):S481-6.
6. 6. Bodey GP, Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis 1989;8:413-37.
7. 7. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26:781-805.
8. 8. Saral R. Candida and aspergillus infections in immunocompromised hosts. an overview Rev Infect Dis 1991;13:487-92.
9. 9. Rinaldi M. Invasive aspergillosis. Rev Infect Dis 1983;5:1061-77.
10. 10. Young R, Bennett J, Vogel C, Carbone P, DeVita V. Aspergillosis: the spectrum of disease in 98 patients. Medicine 1970;49:147-73.
11. 11. Denning D, Stevens D. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990;12: 1147-201.
12. 12. Golladay E, Baker S. Invasive aspergillosis in children. J Pediatr Surg 1987;22: 504-5.
13. 13. Schwartz D, Jacquette M, Chawla H. Disseminated neonatal aspergillosis: report of a fatal case and analysis of risk factors. Pediatr Infect Dis J 1988;7:349-53.
14. 14. Mahoney D, Steuber C, Starling K, Barrett F, Goldberg J, Ferabach D. An outbreak of aspergillosis in children with acute leukemia. J Pediatr 1979;95:70-2.
15. 15. Walmsley S, Devi S, King S, Schneider R, Richardson S, Ford-Jones L. Invasive aspergillus infections in a pediatric hospital: a ten-year review. Pediatr Infect Dis J 1993;12:673-82.
16. 16. Khoo SH, Denning DW. Invasive aspergillosis in patients with AIDS. Clin Infect Dis 1994;19(Suppl 1):S41-8.
17. 17. Minamoto GY, Barlam TF, Vander Els NJ. Invasive aspergillosis in patients with AIDS. Clin Infect Dis 1992;14:66-74.
18. 18. Denning DW, Follansbee SE, Scolaro M, et al. Pulmonary aspergillosis in acquired immune deficiency syndrome. N Engl J Med 1991;324:654-62.
19. 19. Singh N, Yu VL, Rihs JD. Invasive aspergillosis in AIDS. South Med J 1991;84:822-7.
20. 20. Gustafson IL, Schaffner W, Lavely GB, et al. Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis 1983;148:230-8.
21. 21. Bach MC, Adler H., Breman J, et al. Influence of rejection therapy on fungal and noncardiac infections in renal transplant recipients. Lancet 1973;1: 180-4.
22. 22. Aisner J, Muríllo J, Sehimpff S, Steere A. Invasive aspergillosis in acute nonlymphocytic leukemia: correlation with nose cultures and antibiotic use. Ann Intern Med 1979;90:4-9.
23. 23. Treger T, Visscher D, Bartlett M, Smith J. Diagnosis of pulmonary infection caused by Aspergillus: usefulness of respiratory cultures. J Infect Dis 1985;152:572-6.
24. 24. Yu V, Muder R, Poorsattar A. Significance of isolation of Aspergillus from respiratory tract in diagnosis of invasive pulmonary aspergillosis. Am J Med 1986;81:249-54.
25. 25. Nalesnik M, Myerowitz R, Jenkins R, Lenkey J, Herbert D. Significance of Aspergillus species isolated from respiratory secretions in diagnosis of in vasive pulmonary aspergillosis. J Clin Microbiol 1980;11:370-6.
26. 26. Kim M, Shin JH, Suh SP, et al. Aspergillus nidulans infection in a patient with chronic granulomatous disease. J Korean Mod Sci 1997;12:244-8.
27. 27. Dreizen S, Bodey GP, MeCredie KB, Keating MJ, Orofacial aspergillosis in acute leukemia. Oral Surg Oral Med Oral Pathol 1985;59:499-504.
28. 28. Flynn PM, Magill HL, Jenkins JJ, Pearson T, Crist WM, Hughes WT. Aspergillus osteomyelitis in a child treated for acute lymphoblastic leukemia. Pediatr Infect Dis J 1990;9:733-6.
29. 29. Le Moing V, Lortholary O, Timsit J-F. Aspergillus pericarditis with tamponade: report of a successfully treated case and review. Clin Infect Dis 1998;26:451-60.
30. 30. Pruitt AA. Central nervous system infections in cancer patients. Neurol Clin 1991;9:867-88.
31. 31. Walsh T, Hier D, Caplan L. Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Ann Neurol 1985; 18:574-82.
32. 32. Kuhlman JE, Fishman EK, Burch PA, et al. Invasive pulmonary aspergillosis in acute leukemia: the contribution of CT to early diagnosis and aggressive management. Chest 1987;92:95 9.
33. 33. Anaissie EJ, White MH, Uzun O, et al. Amphotericin B lipid complex vs amphotericin B for treatment of invasive candidiasis: a prospective randomized multicenter trial [abstract LM21]. In: Program and abstracts of the 35th Annual Interscience Conference on Antimicrobials and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1995.
34. 34. Walsh TJ, Hiemenz TJ, Scibel NL, et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy. Clin Infect Dis 1998;26:1383-96.
35. 35. Denning DW, Lee JY, Hostler JS, et al. NIAID Mycosis Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 1994;97:135-44.
36. 36. Dupont B. Itraconazole therapy in aspergillosis; study in 49 patients. J Am Acad Dermatol 1990;23:607-14.
37. 37. De Beule K, DeDoncker P, Cauwenbergh G, et al. The treatment of aspergillosis and aspergilloma with itraconazole: clinical results of an open international study (1982-1987). Mycoses 1988;31:476-85.
38. 38. Nemunaitis J, Meyers JD, Buckner CD, et al. Phase 1 trial of recombinant human macrophage colony-stmulating factor in patients with invasive fungal infections. Blood 1991;78:907-13.
39. 39. Rousey SR, Russler S, Gottlieb M, Ash RC. Low-dose amphotericin B prophylaxis against invasive aspergillus infections in allogeneic marrow transplantation. Am J Med 1991;91:484-92.
40. 40. Todeschini G, Murari C, Bonesi R, et al. Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematologic malignancies. Eur J Clin Microbiol Infect Dis 1993;12:614-8.
41. 41. Cowie F, Meller ST, Cushing P, Pinkerton R. Chemoprophylaxis for pulmonary aspergillosis during intensive chemotherapy Arch Dis Child 1994;70:136-8.
42. 42. Mouy R, Veber F, Blanche S, et al. Long-term itraconazole prophylaxis against aspergillus infections in thirty-two patients with chronic granulomatous disease. J Pediatr 1994;125:998-1003.
43. 43. Centers for Disease Control and Prevention. Guidelines for prevention of nosocomial pneumonia. Issues on prevention of nosocomial pneumonia - 1994. Am J Infect Control 1994;22:247-92.